Biomagnetics Diagnostics Corp.
BMGP
$0.00
$0.000.00%
| 03/31/2012 | 09/30/2011 | 06/30/2011 | 03/31/2011 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | -42.66% | -47.01% | -45.53% | 98.47% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -42.66% | -71.58% | -27.96% | 98.47% | |
| Operating Income | 42.66% | 71.58% | 27.96% | -98.47% | |
| Income Before Tax | 38.16% | 78.82% | 30.12% | -80.95% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | 38.16% | 78.82% | 30.12% | -80.95% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | 38.16% | 78.82% | 30.12% | -80.95% | |
| EBIT | 42.66% | 71.58% | 27.96% | -98.47% | |
| EBITDA | 56.61% | 78.79% | 36.99% | -97.36% | |
| EPS Basic | 58.82% | 84.21% | 44.78% | -47.83% | |
| Normalized Basic EPS | 57.14% | 84.72% | 45.24% | -50.00% | |
| EPS Diluted | 58.82% | 84.21% | 44.78% | -47.83% | |
| Normalized Diluted EPS | 57.14% | 84.72% | 45.24% | -50.00% | |
| Average Basic Shares Outstanding | 47.68% | 33.52% | 28.21% | 22.06% | |
| Average Diluted Shares Outstanding | 47.68% | 33.52% | 28.21% | 22.06% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
